Causality is a tricky business in pharmacovigilance. With limited numbers of adverse event reports, how are we supposed to draw conclusions about causal relationships?
Research / 17 November 2020
Better understanding of genetic variation – between individuals and subpopulations – can inform more refined choices of drugs and doses. A new ISoP group is set to drive progress.
Research / 01 July 2020
Catch up with our research team and find out what's keeping a researcher intrigued right now.
Research / 10 April 2020
Despite great progress, real-world data that could be better exploited to research and improve healthcare systems, services and treatments, for the benefit of patients.
Research / 03 April 2020